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Abstract 
Metal-based ethanolamines, (L1)-(L4) coordinated with Co(II), Cu(II), Ni(II) and Zn(II) metals in 
1:2 (metal:ligand) molar ratio to produce new compounds have been reported. These compounds 
were screened for their bactericidal/fungicidal activity against a number of bacterial (Escherichia 
coli, Shigella flexneri, Pseudomonas aeruginosa, Salmonella typhi, Staphylococcus aureus and 
Bacillus subtilis) and fungal strains (Trichophyton longifusus, Candida albicans, Aspergillus 
flavus, Microsporum canis, Fusarium solani and Candida glabrata) alongside against a shrimp 
species known as Artemia salina. The screening results indicated that metal complexes have 
significantly higher activity than uncomplexed ligands against one or more bacterial/fungal species due to 
chelation. The ligand (L4) displayed good bacterial and fungal activity as compared to other ligands. The 
antibacterial results revealed that the Zn(II) complex (16) of (L4) was found to be the most active complex 
and Co(II) complex (14) of the same ligand (L4), demonstrated the highest antifungal activity.  
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Introduction   
Bio-active transition metal complexes have gained increasing interest in metal based drug 
chemistry especially as therapeutic agents. Since their discovery in 1864, Schiff bases have 
contributed immensely to the development of co-ordination chemistry and acting as an 
inspiration for the development of novel compounds1. Schiff bases are characterised by an imine 
group and are formed as a condensation product2 of primary amine with an aldehyde or ketone in 
the presence of a dehydrating agent such as MgSO4. A number of Schiff base metal complexes 
have displayed bioactivity as antibacterial3,4 antifungal5, anticancer6,7A-B, anti-inflammatory8, 
anticonvulsant9, antiviral10 and analgesic11 agents. Although metal based ethanolamines have 
historically been subject of many investigations12,13 due to their use as buffers14, catalysts15, 
inhibitors16, ion exchangers17, electroplating and dyes18, now they are garnering attention for 
their biological19 role in plant growth20 regulation, bacterial and fungal metabolism and as a 
cytotoxic agent21. Metal based compounds have also been reported to improve electron transfer 
and efficiency in protein bioelectrochemistry22a,b. 
One of the advantages of using Schiff bases is the ability to control and tune the electronic and 
steric properties of the ligand attached to the metal. One of the strategies is an appropriate choice 
of precursor, because that plays a pivotal role by allowing control over nature of donor atoms, 
number of chelating moieties and the extent of denticity. The new series of ethanolamine derived 
compounds (L1)-(L4), (E)-2-(((2-hydroxyethyl)imino)methyl)phenol (L1), (E)-2-(((2-
hydroxyethyl)imino)methyl)naphthalen-1-ol (L2), (E)-2-((4-nitrobenzylidene)amino)ethanol (L3) 
and (E)-5-bromo-2-(((2-hydroxyethyl) imino)methyl)phenol (L4) were synthesized from the 
reaction of 2-hydroxy-1-naphthaldehyde, 2-hydroxybezaldehyde, 5-bromo-2-
hydroxybezaldehyde and 4-nitrobenzaldehyde respectively, with ethanolamine in equimolar ratio 
(Scheme 1). The synthesized ligands were further coordinated with Co(II), Cu(II), Ni(II) and 
Zn(II) metals in 1:2 (metal:ligand) molar ratio to produce new metal complexes (Scheme 2). The 
synthesized ligands and their metal(II) complexes have been screened in vitro for anti-bacterial 
activity against six bacterial species (Escherichia coli, Shigella flexneri, Pseudomonas 
aeruginosa, Salmonella typhi, Staphylococcus aureus and Bacillus subtilis) and for in vitro anti-
fungal activity against six fungal strains (Trichophyton longifusus, Candida albicans, Aspergillus 
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flavus, Microsporum canis, Fusarium solani and Candida glabrata). Cytotoxicity of the 
compounds was determined through the help of brine shrimp bioassay. 
Materials and Methods 
All the chemicals used were of analytical grade and were purchased from Sigma Aldrich. Infrared spectra 
of solid compounds (as KBr disc) were recorded on a Nicolet FT-IR Impact 400D infrared spectrometer. 
Elemental analysis was carried out on Perkin Elmer and 1H and 13C NMR spectra were recorded on a 
Bruker Spectrospin Avance DPX-400 spectrometer using TMS as internal standard and d6-DMSO as a 
solvent. Electron impact mass spectra (EIMS) were recorded on JEOL MSRoute instrument. UV-Visible 
spectra were recorded on ultraviolet spectrometer-1700 (Shimadzu, Japan) in the frequency range of 250-
800 nm. Molar conductance of metal complexes was measured using an Inolab Cond 720 Conductivity 
Bridge at room temperature using 0.001 molar solutions in DMF. A Stanton SM12/S Gouy balance was 
used to measure the magnetic susceptibility of the metal complexes at room temperature using mercury 
acetate ligand as a standard. In vitro antibacterial, antifungal and cytotoxic properties were studied in 
collaboration with Research Institute of Chemistry, International Centre for Chemical Sciences, 
University of Karachi, Pakistan and School of Science and Engineering, Teesside University, UK. 
 
 
(Scheme 1) Preparation of Ligands 
 
Synthesis of Ligands 
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Different aldehydes such as 2-hydroxy-1-naphthaldehyde, 2-hydroxybezaldehyde, 5-bromo-2-
hydroxybezaldehyde and 4-nitrobenzaldehyde were individually dissolved in ethanol (25 mL) 
and added respectively to a refluxed solution of ethanolamine in ethanol (10 mL) in an equimolar 
ratio. The reaction mixture was refluxed for 3 hours and consequently precipitated while being 
monitored. The solid product thus obtained was filtered, washed with ethanol and dried. It was 
re-crystallized in hot ethanol/methanol (1:1). The same method was used for the preparation of 
all other ligands (L1)-(L4). 
(E)-2-(((2-Hydroxyethyl)imino)methyl)naphthalen-1-ol (L1)  
Yield: (1.64 g, 76%); mp 151°C; color (dark yellow); IR (KBr, cm-1): 3438 (aryl-OH), 3385 (alc-
OH), 1627 (-HC=N), 1603 (C-H) and 1584 (C=C); 1H NMR (ppm d6-DMSO): δ 3.65 (s, 1H, alc-
OH), 4.50 (t, 2H, C12-H), 5.85 (t, 2H, C11-H), 7.15 (d, 1H, J = 9.0 Hz, C3-H), 7.41 (t, 1H, J = 7.4 
Hz, C6-H), 7.53 (t, 1H, J = 7.4 Hz, C7-H), 7.80 (d, 1H, J = 7.8 Hz, C4-H), 7.95 (d, 1H, J = 9.0 
Hz, C5-H), 8.22 (d, 1H, J = 8.5 Hz, C8-H), 8.53 (s, 1H, C13-H), 9.88 (s, 1H, aryl-OH); 13C NMR 
(DMSO-d6): δ 59.3 (C11), 69.5 (C12), 116.4 (C1), 122.1 (C6), 125.5 (C3), 126.2 (C8), 126.9 (C10), 
127.7 (C7), 128.9 (C5), 134.3 (C9), 136.4 (C4), 159.6 (C2), 162.8 (C13); Mass Spectrum (ESI): 
[M]+ = 215.25. Anal. Calc. for C13H13NO2 (215.25) C, 72.54; H, 6.09; N, 6.51; O, 14.87 and 
found C, 72.48; H 6.04; O, 14.83 
(E)-2-(((2-Hydroxyethyl)imino)methyl)phenol 20 (L2) 
Yield (1.22 g, 74%); mp 92°C; color (yellow); IR (KBr, cm-1): 3450 (aryl-OH), 3380 (alc-
OH),1625 (-HC=N) and 1596 (C=C); 1H NMR (ppm d6-DMSO): δ 3.63 (s, 1H, alc-OH), 4.50 (t, 
2H, C12-H), 5.85 (t, 2H, C11-H), 7.0 (t, 1H, J = 8.5 Hz, C4-H), 7.11 (d, 1H, J = 7.9 Hz, C6-H), 
7.45 (t, 1H, J = 7.5 Hz, C5-H), 7.69 (d, 1H, J = 7.8 Hz, C3-H), 8.50 (s, 1H, C13-H), 9.91 (s, 1H, 
aryl-OH); 13C NMR (DMSO-d6): δ 59.4 (C11), 69.7 (C12), 117.5 (C3), 119.3 (C1), 121.7 (C5), 
131.1 (C6), 133.6 (C4), 159.9 (C2), 162.5 (C13); Mass Spectrum (ESI): [M]+ = 165.19. Anal. 
calcd. for C9H11NO2 (465.19): C, 65.44; H, 6.71; N, 8.48; O, 19.37. Found: C, 65.38; H, 6.67; N, 
19.33.  
(E)-4-Bromo-2-(((2-hydroxyethyl)imino)methyl)phenol (L3) 
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Yield (1.51 g, 78%); mp: 99°C, color (orange yellow); IR (KBr, cm-1): 3453 (aryl-OH), 3382 
(alc-OH), 1622 (-HC=N) and 1590 (C=C); 1H NMR (ppm d6-DMSO): δ 3.67 (s, 1H, alc-OH), 
4.50 (t, 2H, C12-H), 5.85 (t, 2H, C11-H), 7.12 (d, 1H, J = 8.7 Hz, C3-H), 7.50 (dd, 1H, J = 8.7, 
2.5 Hz, C5-H), 8.10 (d, 1H, J = 2.5 Hz, C6-H), 8.57 (s, 1H, C13-H), 9.93 (s, 1H, aryl-OH); 13C 
NMR (DMSO-d6): δ 58.9 (C11), 68.1 (C12), 118.7 (C3), 122.5 (C1), 125.2 (C5), 127.7 (C4), 133.1 
(C6), 159.2 (C2), 161.9 (C13); Mass Spectrum (ESI): [M]+ = 165.19. Anal. calcd. for C9H10BrNO2 
(244.1): C, 44.29; H, 4.13; Br, 32.74; N, 5.74. Found: C, 44.23; H, 4.11; Br, 32.68; N, 5.70.  
(E)-2-((4-Nitrobenzylidene)amino)ethanol (L4) 
Yield (1.55 g, 80%); mp: 88°C, color (reddish brown); IR (KBr, cm-1): 3460 (aryl-OH), 3390 
(alc-OH), 1632 (-HC=N), 1595 (C=C) and 1424 (NO2); 1H NMR (ppm d6-DMSO): δ 3.69 (s, 
1H, alc-OH), 4.50 (t, 2H, C12-H), 5.85 (t, 2H, C11-H), 8.10 (dd, 2H, J = 8.7, 2.5 Hz, C2-H and 
C6-H), 8.33 (dd, 2H, J = 8.7, 2.5 Hz, C3-H and C5-H), 8.65 (s, 1H, C13-H); 13C NMR (DMSO-
d6): δ 59.3 (C11), 68.6 (C12), 120.6 (C3), 122.4 (C5), 130.5 (C1), 131.0 (C6), 152.3 (C4), 158.8 
(C2), 162.2 (C13); Mass Spectrum (ESI): [M]+ = 194.19. Anal. calcd. for C9H10N2O3 (194.19): C, 
55.67; H, 5.19; N, 14.44. Found: C, 55.62; H, 5.16; N, 14.11.  
Synthesis of the Transition Metal(II) Complexes 
All complexes were prepared according to the standard procedure in which a methanol solution 
(20 mL) of the respective metal(II) as a chloride (5 mmol) was added to a refluxed methanol 
solution (30 mL) of the ligand (10 mmol). The mixture was further refluxed for 3 h leading to a 
precipitated product. It was then cooled to room temperature, filtered, washed with methanol and 
finally with diethyl ether. The precipitated product thus obtained was dried and recrystallized in 
a mixture of hot aqueous methanol:ethanol (1:2) to obtain TLC pure product.    
NMR data of the Zn(II) complexes 
[Zn(L1)2] (4): 1H NMR (DMSO-d6, , ppm): 3.78 (s, 1H, alc-OH), 4.61 (t, 2H, C12-H), 5.91 (t, 
2H, C11-H), 7.26 (d, 1H, C3-H), 7.46 (t, 1H, C6-H), 7.59 (t, 1H, C7-H), 7.90 (d, 1H, C4-H), 7.99 
(d, 1H, C5-H), 8.26 (d, 1H, C8-H), 8.64 (s, 1H, C13-H); 13C NMR (DMSO-d6, δ, ppm): 60.1 (C11), 
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70.3 (C12), 117.5 (C1), 129.1 (C6), 125.5 (C3), 126.7 (C8), 127.5 (C10), 128.2 (C7), 129.6 (C5), 
135.0 (C9), 136.4 (C4), 160.6 (C2), 163.9 (C13). 
[Zn(L2)2] (8): 1H NMR (DMSO-d6, , ppm): 3.79 (s, 1H, alc-OH), 4.62 (t, 2H, C12-H), 5.94 (t, 
2H, C11-H), 7.07 (t, 1H, C4-H), 7.18 (d, 1H, C6-H), 7.51 (t, 1H, C5-H), 7.79 (d, 1H, C3-H), 8.63 
(s, 1H, C13-H); 13C NMR (DMSO-d6, , ppm): δ 60.4 (C11), 70.7 (C12), 117.5 (C3), 119.3 (C1), 
123.3 (C5), 131.1 (C6), 134.2 (C4), 161.0 (C2), 163.6 (C13). 
[Zn(L3)2] (12): 1H NMR (DMSO-d6, , ppm): 3.70 (s, 1H, alc-OH), 4.60 (t, 2H, C12-H), 5.95 (t, 
2H, C11-H), 7.23 (d, 1H, C3-H), 7.55 (dd, 1H, C5-H), 8.19 (d, 1H, C6-H), 8.61 (s, 1H, C13-H); 13C 
NMR (DMSO-d6, , ppm): δ 59.8 (C11), 69.1 (C12), 118.7 (C3), 123.5 (C1), 125.7 (C5), 128.3 
(C4), 133.8 (C6), 160.2 (C2), 163.0 (C13). 
 [Zn(L4)2] (16): 1H NMR (DMSO-d6, , ppm): 4.59 (t, 2H, C12-H), 5.93 (t, 2H, C11-H), 8.18 (dd, 
2H, C2-H and C6-H), 8.39 (dd, 2H, C3-H and C5-H), 8.62 (s, 1H, C13-H), 10.3 (s, 4H, H2O); 13C 
NMR (DMSO-d6, , ppm): δ 60.2 (C11), 69.7 (C12), 121.4 (C3), 122.9 (C5), 131.5 (C1), 131.8 
(C6), 152.9 (C4), 159.7 (C2), 163.3 (C13). 
Biological Activity  
Antibacterial Activity (in vitro) 
All the newly synthesized ethanolamine derived compounds (L1)-(L4) and their metal(II) 
complexes (1)-(16) were screened in-vitro for their antibacterial activity against four Gram-
negative (E.  coli, S. flexneri, P. aeruginosa, S. typhi) and two Gram-positive (S. aureus, B. 
subtilis) bacterial strains by agar-well diffusion method24. The wells (6 mm in diameter) were 
dug in the media with the help of a sterile metallic borer with centers at least 24 mm apart. Two 
to eight hours old bacterial inocula containing approximately 104-106 colony-forming units 
(CFU/mL) were spread on the surface of the nutrient agar with the help of a sterile cotton swab. 
The recommended concentration of the test sample (1mg/mL in DMSO) was introduced in the 
respective wells. Other wells supplemented with DMSO and reference antibacterial drug 
(imipenem) served as a negative and positive control, respectively. The plates were incubated at 
37°C for 24 h. Activity was determined by measuring the diameter of clear zones showing 
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complete inhibition (mm). In order to confirm the effect of DMSO in the biological screening, 
alternate studies on DMSO solution showed no activity against any bacterial strains. 
Antifungal Activity (in vitro) 
Antifungal activity was studied against six fungal strains (T. longifusus, C. albican, A. flavus, M. 
canis, F. solani and C. glabrata). Sabouraud dextrose agar (Oxoid, Hampshire, England) was 
seeded with 105 (cfu) mL-1 fungal spore suspensions and transferred to petri plates. Discs soaked 
in 20 mL (200 µg/mL in DMSO) of the compounds were placed at different positions on the agar 
surface. The plates were incubated at 32°C for 7 days. The results were recorded as %age of 
inhibition and compared with standard drugs miconazole and amphotericin B. 
 Minimum Inhibitory Concentration (MIC) 
Compounds containing promising antibacterial activity were selected for minimum inhibitory 
concentration (MIC) studies. The minimum inhibitory concentration was determined using the 
disc diffusion technique25 by preparing discs containing diluted samples at 10, 25, 50 and 100 g 
mL-1 concentrations of the compounds along with standards at the same concentrations. 
Cytotoxicity (In vitro) 
Brine shrimp assay was done using the protocol of Meyer et al. 26, the details of which are 
reproduced here. Brine shrimp (Artemia salina leach) eggs were hatched in a shallow rectangular 
plastic dish (22×32 cm), filled with artificial seawater prepared from commercial salt mixture 
and double distilled water. An unequal partition was made in the plastic dish with the help of a 
perforated device where approximately 50 mg of eggs were sprinkled into the darkened larger 
compartment while smaller matter compartment was exposed to the ordinary light. After two 
days, nauplii were collected from the unsheltered side. A sample of the test compound was 
prepared by dissolving 20 mg of each compound in 2 mL of DMF. From this stock solutions 5, 
50 and 500 µg/mL were transferred to 9 vials (three for each dilutions were used for each test 
sample and LD50 was calculated as the mean of these three values) and one vial was kept as 
control having 2 mL of DMF only. The solvent was allowed to evaporate overnight. After two 
days, when shrimp larvae were ready, 1 mL of seawater and 10 shrimps were added to each vial 
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(30 shrimps/ dilution) and the volume was adjusted with seawater to 5 mL per vial26. After 24 h 
the number of survivors was counted. Data were analyzed by a computer program to determine 
the LD50 values27.  
Results and Discussion 
The condensation reaction of ethanolamine with 2-hydroxy-1-naphthaldehyde/2-
hydroxybenzaldehyde/5-bromo-2-hydroxybenzaldehyde/4-nitrobenzaldehyde in an equimolar 
ratio afforded four ligands (L1)-(L4) (Scheme 1). These coloured ligands were stable in both air 
and moisture. These microcrystalline solids melted at 155-280 °C and were soluble in DMSO 
and DMF at room temperature and  in methanol and ethanol on heating. The ligands (L1)-(L3) 
were found to be tridentate and (L4) to be bidentate which reacted readily with Co(II), Cu(II), 
Ni(II) and Zn(II) metals as their chlorides in methanol to form their metal(II) complexes 
(Scheme 2). 
 
 9 
(Scheme 2) Metal(II) Complexes 
All the synthesized metal(II) complexes were microcrystalline and had an intense color except 
Zn(II) complexes which were off-white. The metal(II) complexes decomposed without melting 
and were insoluble in common organic solvents such as ethanol, methanol, dichloromethane and 
acetone but soluble in DMSO and DMF. The spectral data and elemental analysis of the prepared 
ligands and their metal(II) complexes were in a good agreement with their proposed structures, 
indicating the high purity of all the compounds. The analytical data of the complexes indicated a 
1:2 metal: ligand stoichiometry.  
Table 1. Physical Measurements and Analytical Data of Metal(II) Complexes (1)-(16). 
No Structure 
Yield 
(%) 
MW/ Formula 
M.P 
(oC) 
Elemental Analysis (%) 
Calc (Found) 
C H N M 
(1) [Co(L1-H)2] 70 [487.41] 
C26H24N2O4Co 
166-168 64.07  
(64.01) 
4.96     
(4.92) 
5.75        
(5.72) 
12.09 
(12.04) 
(2) [Ni(L1-H)2] 70 [487.17] 
C26H24N2O4Ni 
220-222 64.10  
(64.01) 
4.97     
(4.92) 
5.75        
(5.71) 
12.05 
(12.01) 
(3) [Cu(L1-H)2] 75 [492.02]   
C26H24N2O4Cu 
185-187 64.77  
(64.71) 
4.92     
(4.89) 
5.69        
(5.65) 
12.92 
(12.88) 
(4) [Zn(L1-H)2] 83      [493.89]  
C26H24N2O4Zn 
197-199 63.23  
(63.18) 
4.90     
(4.86) 
5.67        
(5.62) 
13.24 
(13.20) 
(5) [Co(L2-H)2] 71 [387.30] 
C18H20N2O4Co 
175-176 55.82 
(55.77) 
5.21 
(5.18) 
7.23 
(7.20) 
15.22 
(15.18) 
(6) [Ni(L2-H)2] 74 [387.06] 
C18H20N2O4Ni 
230-232 55.86 
(55.80) 
5.21 
(5.17) 
7.24 
(7.20) 
15.16 
(15.12) 
(7) [Cu(L2-H)2] 81 [391.91]   
C18H20N2O4Cu 
194-196 55.16 
(55.11) 
5.14 
(5.10) 
7.15 
(7.12) 
16.21 
(16.17) 
(8) [Zn(L2-H)2] 82      [393.77]  
C18H20N2O4Zn 
270-272 54.90 
(54.85) 
5.12 
(5.09) 
7.11 
(7.06) 
16.61 
(16.56) 
(9) [Co(L3-H)2] 85 [545.09] 
C18H18Br2N2O4Co 
225-227 39.66 
(39.61) 
3.33 
(3.29) 
5.14 
(5.11) 
10.81 
(10.77) 
(10) [Ni(L3-H)2] 80 [544.85] 
C18H18Br2N2O4Ni 
194-196 39.68 
(39.64) 
3.33 
(3.29) 
5.14 
(5.10) 
10.77 
(10.73) 
(11) [Cu(L3-H)2] 84 [549.70] 
C18H18Br2N2O4Cu 
214-216 39.33 
(39.29) 
3.30 
(3.27) 
5.10 
(5.07) 
11.56 
(11.52) 
(12) [Zn(L3-H)2] 80       [551.56]      
C18H18Br2N2O4Zn 
211-212 39.20 
(39.15) 
3.29 
(3.26) 
5.08 
(5.04) 
11.86 
(11.82) 
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(13) [Co(L3-H)2] 74 [481.32] 
C18H22N4O8Co 
176-177 44.92 
(44.87) 
4.61 
(4.57) 
11.64 
(11.60) 
12.24 
(12.20) 
(14) [Ni(L3-H)2] 82 [481.07] 
C18H22N4O8Ni 
206-208 44.94 
(44.89) 
4.61 
(4.58) 
11.65 
(11.60) 
12.20 
(12.16) 
(15) [Cu(L3-H)2] 77 [485.84] 
C18H22N4O8Cu 
190-191 44.49 
(44.44) 
4.56 
(4.53) 
11.53 
(11.50) 
13.08 
(13.05) 
(16) [Zn(L3-H)2] 78       [487.80]      
C18H22N4O8Zn 
278-280 44.32 
(44.27) 
4.55 
(4.51) 
11.49 
(11.45) 
13.41 
(13.37) 
IR Spectra 
The significant and distinctive IR spectral bands are reported in the experimental part and in 
Table 2. All Schiff base ligands possessed potentially active donor sites capable of coordinating 
with metal atoms such as azomethine nitrogen (-HC=N), aliphatic and aromatic hydroxyl (-OH) 
groups. The Schiff bases (L1)-(L4) possessed the characteristic azomethine (-HC=N) stretching28 
at 1622-1632 cm-1 giving a clue of condensation product. All the ligands (L1)-(L4) displayed 
aliphatic hydroxyl (-OH) stretching at 3380-3390 cm-1, however, ligands (L1)-(L3) additionally 
showed aromatic hydroxyl (-OH) stretching29 at 3438-3390 cm-1. The ligand (L4) showed a band 
at 1424 cm-1 resulting from NO2 vibrations. The comparison of the IR spectra of the Schiff bases 
(L1)-(L4) with their metal(II) complexes (1)-(16) indicated that the Schiff bases were principally 
coordinated to the metal(II) atoms in a bi- and tridentate fashion. The vibrations of azomethine-N 
group present in all the metal complexes (1)-(16) and aliphatic-O appearing in the spectra of 
metal(II) complexes (1)-(12) shifted to lower frequency (07-15 cm-1) at 1608-1623 and 3365-
3377 cm-1 respectively, representing the mode of coordination of the azomethine nitrogen30 and 
hydroxyl-O with the metal(II) atoms. Absence of bands at 3438-3490 and 3380-3390cm-1 due to 
aliphatic and aromatic ν(OH) and consequent appearance of a new band31 at 1370-1377 cm-1 
attributed to ν(C-O) in the metal(II) complexes (1)-(16), confirmed the deprotonation and 
coordination of aromatic and aliphatic ν(OH) to the metal(II) atoms. The following observations 
further support the mode of chelation: 
 Appearance of the new bands at 520-543 and 440-460 cm-1 could be assigned to v(M-O) 
and v(M-N) vibrations32 in the metal complexes which are absent in ligands.  
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 The metal(II) complexes (13)-(16) demonstrated33 new broad bands at 3468-3478 cm-1 
which can likely be attributed to water molecules coordinated to the metal atoms. These 
bands were only observed in the spectra of the metal complexes.  
These clues supported the evidence of the participation of azomethine-N and 
deprotonation/coordination of hydroxyl-O with the metal(II) ions.  
 
Table 2. Conductivity, Magnetic and Spectral Data of Metal(II) Complexes (1)-(16)   
No 
     
ΩM                 
(Ω-1cm2mol-1) 
B.M 
μeff 
λm 
(cm-1) 
IR (cm-1) 
(1) 15.9 4.35 8723, 17690, 29820  3370 (OH), 1616 (HC=N), 1370 (C-O), 
520 (M-N), 442 (M-O)  
(2) 15.7 3.56 8635, 17717, 25817, 29781 3372 (OH), 1615 (HC=N), 1372 (C-O), 
535 (M-N), 450 (M-O) 
(3) 14.6 1.66 8897, 17783, 29816 3371 (OH), 1620 (HC=N), 1373 (C-O), 
529 (M-N), 448 (M-O) 
(4) 14.9 Dia 28915 3373 (OH), 1618 (HC=N), 1371 (C-O), 
533 (M-N), 450 (M-O) 
(5) 16.2 4.53 8650, 17729, 29841 3366 (OH), 1612 (HC=N), 1372 (C-O), 
522 (M-N), 446 (M-O) 
(6) 15.8 3.41 8712, 17761, 25778, 29738 3365 (OH), 1610 (HC=N), 1370 (C-O), 
536 (M-N), 445 (M-O) 
(7) 15.6 1.71 8937, 17892, 29812 3365 (OH), 1615 (HC=N), 1371 (C-O), 
526 (M-N), 443 (M-O) 
(8) 15.1 Dia 28928 3368 (OH), 1613 (HC=N), 1373 (C-O),  
532 (M-N), 440 (M-O) 
(9) 16.2 4.38 8680, 17523, 29831 3368 (OH), 1611 (HC=N), 1377 (C-O), 
540 (M-N), 449 (M-O) 
(10) 15.2 3.48 8786, 17777, 25719, 29781 3367 (OH), 1610 (HC=N), 1376 (C-O), 
524 (M-N), 453 (M-O) 
(11) 16.0 1.74 8727, 17765, 29788 3370 (OH), 1612 (HC=N), 1375 (C-O), 
536 (M-N), 448 (M-O) 
(12) 15.0 Dia 28841 3377 (OH), 1608 (HC=N), 1377 (C-O), 
528 (M-N), 451 (M-O) 
(13) 14.6 4.45 8790, 17800, 29805 3470 (H2O), 1620 (HC=N), 540 (M-N), 
455 (M-O) 
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(14) 16.5 3.51 8696, 17871, 25719, 29778 3471 (H2O), 1622 (HC=N), 544 (M-N), 
459 (M-O) 
(15) 15.4 1.70 8866, 17857, 29858 3470 (H2O), 1623 (HC=N), 541 (M-N), 
460 (M-O) 
(16) 15.1 Dia 28932 3473 (H2O), 1619 (HC=N), 543 (M-N), 
463 (M-O) 
1H NMR Spectra 
1H NMR spectra of the ligands (L1)-(L4) and their diamagnetic Zn(II) complexes were recorded 
in DMSO-d6 and the details are provided in the experimental section. 1H NMR spectra 
displayed34 characteristic azomethine (-HC=N) protons at 8.53-8.65 ppm as a singlet providing a 
strong evidence for condensation of amino group of the ethanolamine with aldehydes. All of the 
ligands (L1)-(L4) displayed aliphatic (-OH) proton at 5.63-5.99 ppm as a singlet and C11-H and 
C12-H protons at 4.50 and 5.85 ppm as triplet, respectively. The ligands (L1)-(L3) possessed 
aromatic (-OH) proton at 9.88-9.93 ppm. Ligand (L1) displayed other C3-5-H and C8-H protons as 
a double of doublet at 7.15-8.22 ppm, respectively but C6-H and C7-H protons appeared as a 
triplet at 7.41 and 7.53 ppm, respectively. Similarly, the ligand (L2) exhibited C4-H and C5-H 
protons at 7.0 and 7.45 ppm as triplet and, C3-H and C6-H protons as a doublet at 7.11 and 7.69 
ppm respectively. The C3-H and C6-H protons of ligand (L3) were found at 7.12 and 8.10 ppm as 
a doublet and C5-H proton observed at 7.50 ppm as a double of doublet.  1H NMR spectra of the 
ligand (L4) showed the C2-H, C6-H and, C3-H and C5-H protons at 8.10 and 8.33 ppm as double 
of doublet. The disappearance of hydroxyl proton at 9.88-9.93 ppm in the spectra of Zn(II) 
complexes confirmed deprotonation and coordination of the hydroxyl-O with the metal atom. 
The coordination of the azomethine-N was evident by downfield shifting of all the proton signals 
in their Zn(II) complexes. A strong singlet was observed at 10.3 ppm in the Zn(II) complex (16) 
due to the coordination of water molecule with the Zn(II) metal atom. All protons underwent 
downfield shift by 0.05-0.12 ppm due to the increased conjugation on coordination with the zinc 
metal atom. The number of protons calculated from the integration curves32 and obtained values 
of the expected CHN analysis agreed well with each other. 
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13C NMR Spectra  
The 13C-NMR spectra of the Schiff bases and their diamagnetic Zn(II) complexes were recorded 
in DMSO-d6 and are reported along with their possible assignments in the experimental section 
and all the carbon atoms were found in the expected region. The 13C-NMR spectra of the Schiff 
base ligands (L1)-(L4) displayed distinctive and representative (C11, C12) carbons of ethylene 
group and (C13) carbons of azomethine (-HC=N) at 58.9-69.7 and 161.9-162.8 ppm respectively. 
The remaining other (C1)-(C10) carbons of aromatic rings were observed at 116.4-159.9 ppm. 
Downfield shifting of the azomethine carbons found in the uncomplexed Schiff bases from 
161.9-162.8 ppm to 163.0-163.9 ppm in their Zn(II) complexes was due to shifting of electronic 
density towards the Zn(II) ion. Similarly, all carbons of methylene groups and aromatic rings 
being near to the coordination sites also showed downfield shifting by 0.5-1.1 ppm due to the 
increased conjugation and coordination with the metal atoms. The downfield shifting also 
confirmed the coordination of the azomethine to the zinc metal atom. Moreover, the presence of 
the number of carbons are well in agreement with the expected values35. Furthermore, the 
conclusions drawn from these studies present further support to the modes of bonding discussed 
in their IR and 1H NMR spectra. 
Mass Spectra  
The mass fragmentation pattern of the ligands (L1)-(L3) followed the cleavage of C=N 
(exocyclic) and C=C bonds. The mass spectral data and the stable fragmentation values of the 
ligands have already been detailed in the experimental section. All the ligands showed 
pronounced molecular ion peaks. The data of the Schiff bases shown by mass spectra strongly 
confirmed the formation of the ligands possessing proposed structures and also, their bonding 
pattern.  
Molar Conductances and Magnetic Measurements 
Molar conductance studies of the metal(II) complexes (1)-(16) were carried out in DMF and their 
molar conductance data (14.6-16.9 ohm-1 cm2 mol-1) showed that these complexes were non 
electrolytic36 in nature. The magnetic moment (B.M) values of all the metal(II) complexes (1)-
(16) were measured at room temperature. The observed magnetic moment value of Co(II) 
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complexes were found in the range of 4.35-4.53 B.M indicating that Co(II) complexes as a high-
spin with potentially three unpaired electrons in an octahedral environment37. The Ni(II) 
complexes displayed magnetic moment values in the range of 3.41-3.56 B.M indicative of two 
unpaired electrons per Ni(II) ion suggesting these complexes to have an octahedral38 geometry. 
The measured magnetic moment values 1.66-1.74 B.M for Cu(II) complexes are indicative of 
one unpaired electron per Cu(II) ion for d9-system suggesting octahedral39 geometry. All the 
Zn(II) complexes were found to be diamagnetic40 as expected.  
Electronic Spectra 
The electronic spectra of Co(II) complexes generally showed40 three absorption bands in the 
region 8650-8790, 17523-17800 and 29805-29841cm-1 which may be assigned to 
4T1g→4T2g(F), 4T1g→4A2g(F) and 4T1g→4Tg(P) transitions respectively, and are suggestive 
of octahedral geometry around the Co(II) ion. The electronic spectral data of Ni(II) complexes 
showed41 the bands in the region 8635-8786, 17717-17871 and 25719-25717 cm-1 assigned 
respectively, to the d-d transitions of 3A2g(F)→3T2g(F) and 3A2g(F)→3T1g(F). Also a strong 
band due to metal to ligand charge transfer was appeared at 29738-29781 cm-1. The electronic 
spectra of all the Cu(II) complexes exhibited42 absorption bands in the region at 8727-8937 and 
17765-17892 cm-1 which may be assigned to the transitions 2Eg→2T2g. The high energy band at 
29788-29858 cm-1 was due to forbidden ligand to metal charge transfer. On the basis of 
electronic spectra, octahedral geometry around the Cu(II) ion was suggested. The Zn(II) 
complexes did not show any d-d transition thus showing diamagnetic nature and their spectra 
were dominated only by a charge transfer band43 at 28841-28932 cm-1. 
Biological Screening 
Antibacterial Bioassay (in vitro) 
The newly produced Schiff bases (L1)-(L4) and their metal(II) complexes (1)-(16) were screened 
of their in-vitro antibacterial activity against Escherichia coli, Shigella flexneri, Pseudomonas 
aeruginosa, Salmonella typhi, Staphylococcus aureus and Bacillus subtilis bacterial strains 
according to the standard procedures24 and results are reported in Table 3. The obtained results 
were compared with those of the standardized drug sample of imipenum. The synthesized ligand 
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(L1) displayed a weaker (07-08 mm clearance zone (cz) or zone of inhibition) activity against 
Escherichia coli and Bacillus subtilis and the remaining strains displayed moderate (10-13 mm) 
activity. Ligand (L2) presented a weaker (8 mm) activity against Salmonella typhi and the 
remaining strains showed moderate (9-13 mm) activity. Ligand (L3) demonstrated moderate (11-
12 mm) activity against Shigella flexneri, Pseudomonas aeruginosa and Bacillus subtilis and, 
other remaining strains observed significant (16-17 mm) activity. The ligand (L4) experienced 
overall significant (15-17 mm) activity. The metal complex (1) showed moderate (14 mm) 
activity against Escherichia coli and Bacillus subtilis and other remaining strains experienced 
significant (15-19 mm) activity. Complex (2) showed moderate (12-14 mm) activity against 
Pseudomonas aeruginosa and Bacillus subtilis and left behind strains practiced significant (17-
18 mm) activity. Compound (3) exhibited moderate (12-13 mm) activity against Salmonella 
typhi and Bacillus subtilis and, left over demonstrated significant (16-18 mm) activity. Beside 
this, the compound (4) revealed significant (15-20 mm) activity against all bacterial strains 
except Escherichia coli which observed moderate (13 mm) activity. Also, the complexes (5) and 
(6) displayed moderate (12-14 mm) activity against Salmonella typhi and Staphylococcus aureus 
and, remaining strains revealed significant (17-19 mm) activity. However, the complexes (7)-
(16) displayed overall significant (15-25 mm) activity against all bacterial strains. The data 
reported in Table 3 clearly indicates that (L4) exhibited overall good bacterial activity as 
compared to other three ligands. The Zn(II) complex (16) of (L4) were found to be the most 
active complexes. The metal(II) complexes showed41 higher activity results upon complexation 
rather than their uncomplexed Schiff bases.  
Table 3.  Antibacterial Bioassay of Ligands (L1)-(L4) and Metal(II) Complexes (1)-(16)  
[Zone of Inhibition (mm)] 
 Gram-negative Gram-positive  
Compounds (a) (b) (c) (d) (e) (f) (SA) Average 
(L1) 08 13 11 10 13 07 2.50 10.33 
(L2) 13 11 12 08 09 11 1.86 10.67 
(L3) 16 12 11 17 16 12 2.61 14.00 
(L4) 16 17 15 17 16 15 0.89 16.00 
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(1) 14 19 17 15 19 14 2.59 16.50 
(2) 17 18 12 17 18 14 2.45 16.00 
(3) 16 17 18 13 16 12 2.34 15.33 
(4) 13 16 19 16 20 15 2.59 16.50 
(5) 18 17 19 14 12 18 2.73 16.33 
(6) 16 18 16 13 14 16 1.76 15.50 
(7) 17 19 15 16 16 16 1.38 16.50 
(8) 20 17 19 15 16 17 2.50 17.67 
(9) 20 21 17 22 22 18 2.10 20.00 
(10) 22 16 19 19 23 21 2.53 20.00 
(11) 20 17 16 21 19 20 1.94 18.83 
(12) 18 24 19 23 20 21 2.32 20.83 
(13) 21 23 16 20 19 18 2.58 19.67 
(14) 20 17 21 22 24 22 2.37 21.00 
(15) 19 22 17 19 25 20 2.80 20.33 
(16) 22 21 22 24 21 21 1.17 21.83 
SD 25 26 25 27 27 28 1.17 25.83 
Average Activity of Ligand (L1)-(L4) = 12.75 mm; Average Activity of Complexes (1)-(16) 
 = 18.74 mm; (a) E.  Coli  (b)  S. flexneri (c) P. Aeruginosa (d)  S. Typhi (e) S. Aureus (f)  B. 
Subtilis; SD: Standard Drug (Imipenum); weaker = 0-08 mm, moderate = 09-14 mm,  above 
14 mm = significant, SA = Statistical Analysis 
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Figure 1. Comparison of Antibacterial Activity of Schiff bases versus Metal(II) Complexes 
 
Antifungal Bioassay (in-vitro) 
 
The antifungal screening of all the synthesized compounds was carried out against Trichophyton 
longifusus, Candida albicans, Aspergillus flavus, Microsporum canis, Fusarium solani and 
Candida glabrata fungal strains Table 4 according to the literature protocol22. The results of 
inhibition were compared with the results of standard drugs, miconazole and amphotericin B. 
Ligand (L1) exhibited significant (55%) activity against Aspergillus flavus fungal strain, 
moderate (37-45%) activity against Trichophyton longifusus, Microscopum canis and Candida 
glabrata and weaker (17%) activity against Candida albicans and but inactive against Fusarium 
solani begging further investigation why that may be? Similarly, the ligand (L2) posessed 
significant (56%) activity against Candida albicans and moderate (38-49%) activity against 
Trichophyton longifusus, Aspergillus flavus, Fusarium solani, weaker (30%) activity against 
Candida glabrata but no activity was observed in Aspergillus flavus. However, (L3) and (L4) 
displayed overall significant (55-63%) activity against all fungal strains. The complex (1) 
displayed significant (61-63%) activity against Trichophyton longifusus, Aspergillus flavus and 
Candida glabrata fungal strains, moderate (37-50%) activity against Candida albicans and 
Microsporum canis, and weaker (16%) activity against Fusarium solani. Likewise, complex (2) 
had significant (55-77%) activity against Trichophyton longifusus, Aspergillus flavus, 
Microsporum canis, and Candida glabrata, and displayed weaker (25-26%) activity against 
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remaining two strains. Similarly the compound (3) demonstrated significant (55-69%) activity 
against Trichophyton longifusus, Aspergillus flavus, Microsporum canis, and Candida glabrata, 
moderate (42%) against Candida albicans and weaker (23%) activity against Fusarium solani. 
The complex (4) comparably possessed significant (55-65%) activity against Trichophyton 
longifusus, Aspergillus flavus, Microsporum canis, and Candida glabrata and moderate (36-
37%) activity was observed with rest of the fungal strains. On the other hand, the compound (5)-
(8) showed overall significant (55-75%) activity against all strains except Microsporum canis 
which displayed weaker (17-30%) activity. The compounds (9)-(16) displayed overall significant 
(55-78%) activity against fungal strains due to Br and NO2 groups attached with the aromatic 
rings. (L4) showed overall good fungal activity as compared to other three ligands due to nitro 
substitution. The Co(II) complex (14) of (L4) was found to be the most active complex. The 
metal(II) complexes showed enhanced45 activity results rather than their uncomplexed Schiff 
bases upon complexation.  
Table 4.  Antifungal Bioassay of Ligands (L1)-(L4) and Metal(II) Complexes (1)-(16)  
[% Inhibition (mm)] 
Compounds (a) (b) (c) (d) (e) (f) (SA) Average 
(L1) 45 17 55 37 00 40 20.18 32.33 
(L2) 38 56 49 00 43 30 19.77 36.00 
(L3) 56 60 61 56 63 59 2.79 59.17 
(L4) 62 58 59 63 61 55 2.94 59.67 
(1) 62 37 63 49 16 61 18.63 48.00 
(2) 55 25 75 77 26 58 22.81 52.67 
(3) 59 42 62 55 23 69 16.66 51.67 
(4) 65 36 64 56 37 57 12.91 52.50 
(5) 57 68 66 17 75 66 20.97 58.17 
(6) 61 69 72 28 69 71 16.94 61.67 
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(7) 55 73 67 30 66 75 16.72 61.00 
(8) 56 64 68 25 68 69 17.03 58.33 
(9) 71 75 70 67 72 74 2.88 71.50 
(10) 75 69 57 73 70 67 6.32 68.50 
(11) 69 74 70 65 69 65 3.39 68.67 
(12) 70 78 68 74 73 60 6.19 70.50 
(13) 72 75 70 61 72 64 5.37 69.00 
(14) 78 65 57 73 70 67 7.20 68.33 
(15) 69 58 70 65 72 65 5.01 66.50 
(16) 75 68 72 77 79 68 4.62 73.17 
SD A B C D E F - - 
 Average Activity of Ligands (L1)-(L4)  =  46.79%; Average Activity of Complexes (1)-(16) = 
62.51%; (a) T. Longifusus (b) = C. Albicans (c) = A. Flavus (d) = M. Canis (e) = F. Solani (f) = 
C. Glabrata SD = Standard Drugs MIC µg/mL; A = Miconazole (70 µg/mL:1.6822x10-7 M/mL), 
B = Miconazole (110.8 µg/mL:2.6626x10-7 M/mL), C = Amphotericin B (20 µg/mL:2.1642x10-8 
M/mL), D = Miconazole (98.4 µg/mL:2.3647x10-7 M/mL), E = Miconazole (73.25 µg/mL: 
1.7603x10-7 M/mL), F = Miconazole (110.8 µg/mL: 2.66266x10-7 M/mL); weaker = 0-33%, 
moderate = 34-54%, 55-100% = significant; SA = Statistical Analysis. 
 
Figure 2. Comparison of Antifungal Activity of Schiff bases versus Metal(II) Complexes 
Minimum Inhibitory Concentration (MIC)   
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The synthesized ligands and their transition metal(II) complexes showing promising antibacterial 
activity (> 80%) were selected for MIC studies i.e. (9), (10) and (12)-(16) and the results are 
reported in Table 5. The MIC values of these compounds fall in the range 23.11 to 46.62g/mL.  
Amongst these, the compound (14) was found to be the most active possessing maximum 
inhibition 16.11 µg/mL against bacterial strain S. Aureus.    
Cytotoxicity (In-vitro) 
The Schiff bases and their vanadyl(IV) complexes were screened for their cytotoxicity (brine 
shrimp bioassay) by using Meyer protocol26. The data recorded in Table 6 indicate that none of 
the compounds either ligands or complexes showed cytotoxicty (1.64 × 10-3 to 4.71 × 10-3) 
against Artemia salina. This activity relationship may help to serve as a basis for future direction 
towards the development of certain cytotoxic agents for clinical applications. 
 
Table 5.  Minimum Inhibitory Concentration (µg/mL) of the Selected Compounds (9), (10) and 
(12)-(16) against Selected Bacteria. 
Compounds E.  Coli S. Flexneri P. Aeruginosa S. Typhi S. Aureus 
(9) - 46.21 - 37.16 25.17 
(10) 30.16 - - - 39.24 
(12) - 36.35 - 43.22 - 
(13) 23.71 28.67 - - - 
(14) - - 32.11 46.62 16.11 
(15) - 25.00 - - 26.35 
(16) 39.10 18.17 42.65 25.31 - 
Table 6.  Cytotoxicity (In vitro) of Ligands (L1)-(L4) and their Metal(II) Complexes (1)-(16) 
Compounds   LD50 (M/mL) Compounds   LD50 (M/mL) Compounds   LD50 (M/mL) 
(L1) >2.19 × 10-3 (4) >1.64 × 10-3 (11) >4.71 × 10-3 
(L2) >1.81 × 10-3 (5) >3.19 × 10-3 (12) >2.68 × 10-3 
(L3) >3.11 × 10-3 (6) >4.04 × 10-3 (13) >2.51 × 10-3 
(L4) >2.19 × 10-3 (7) >4.59 × 10-4 (14) >2.11 × 10-3 
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(1) >3.81 × 10-3 (8) >2.81 × 10-3 (15) >4.19 × 10-4 
(2) >2.11 × 10-3 (9) >3.15 × 10-3 (16) >3.81 × 10-3 
(3) >4.10 × 10-3 (10) >1.98 × 10-3   
 
 
Conclusions  
 
The synthesized ethanol derived Schiff bases act as bi and tridentate ligands for coordination 
with the Co(II), Cu(II), Ni(II) and Zn(II) metal atoms. Physical (magnetic and molar 
conductance), spectral (IR, NMR, electronic) and analytical (C, H, N and V percentage) data 
confirmed that the Schiff base ligands are coordinated with the Co(II), Cu(II), Ni(II) and Zn(II) 
metal atoms via azomethine-N, naphthalene-O, salicylidene-O and ethanol-O showing an 
octahedral geometry. The obtained results of antibacterial and antifungal activities indicated that 
the metal complexes possessed better biological activity against one or more bacterial and/or 
fungal strains as compared to their parent uncomplexed ligands. It can be asserted that 
azomethine-N, nitro, bromo and oxygen were the functional groups in the compounds potentially 
responsible for the enhancement of bacterial and fungal activities. However, brine shrimp assays 
revealed that these compounds were limited in their cytotoxicity hinting at some divergent 
apoptotic mechanisms. 
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